Figure 5
Figure 5. Primary ATL patient samples are characterized by a high rate of STAT3 mutations and a strong correlation between STAT3 and Pim1. (A). Correlation of STAT3 and Pim1 in ATL patients. Real-time PCR analysis of STAT3 (red) and Pim1 (steel blue) expression in primary ATL patients (n = 48). Statistical analysis was carried out using Spearman’s correlation coefficient. Corresponding P values and linear regression values are indicated. GAPDH amplification served as an internal control. Mutational status of the STAT3 hotspot region is indicated below the corresponding patient. *, mutated; WT, wild-type; NA, not available. (B) Illustration of the STAT3 protein indicating the SH2 domain where frequent ATL STAT3 mutations were found. (C) A representational example of STAT3 mutations found in individual ATL patients. Arrows highlight the specific point mutation in the sequence, with the corresponding nucleotide change below. (D) Primary ATL patients have a 25.5% percentage of STAT3 mutations. Table demonstrating individual STAT3 mutations found in ATL patients. The consequence of each mutation, if known, is highlighted. UN, unknown.

Primary ATL patient samples are characterized by a high rate of STAT3 mutations and a strong correlation between STAT3 and Pim1. (A). Correlation of STAT3 and Pim1 in ATL patients. Real-time PCR analysis of STAT3 (red) and Pim1 (steel blue) expression in primary ATL patients (n = 48). Statistical analysis was carried out using Spearman’s correlation coefficient. Corresponding P values and linear regression values are indicated. GAPDH amplification served as an internal control. Mutational status of the STAT3 hotspot region is indicated below the corresponding patient. *, mutated; WT, wild-type; NA, not available. (B) Illustration of the STAT3 protein indicating the SH2 domain where frequent ATL STAT3 mutations were found. (C) A representational example of STAT3 mutations found in individual ATL patients. Arrows highlight the specific point mutation in the sequence, with the corresponding nucleotide change below. (D) Primary ATL patients have a 25.5% percentage of STAT3 mutations. Table demonstrating individual STAT3 mutations found in ATL patients. The consequence of each mutation, if known, is highlighted. UN, unknown.

Close Modal

or Create an Account

Close Modal
Close Modal